Role of the Reverse Transcriptase Tryptophan Repeat Motif in HIV-1 Replication

Role of the Reverse Transcriptase Tryptophan Repeat Motif in HIV-1 Replication

Author: Johanna A. Wapling

Publisher:

Published: 2011

Total Pages: 221

ISBN-13:

DOWNLOAD EBOOK

The HIV-l enzyme, reverse transcriptase (RT), is a successful target for antiretroviral agents used for the treatment of HI VIA IDS. Ongoing research indicates that RT may yet reveal further targets for the development of novel chemotherapeutic agents that act to inhibit HIV -1 replication. R T is an asymmetric heterodimer composed of the p66 (66 kDa) and pSI (51 kDa) subunits. Since characterisation ofRT as an obligate dimer, subunit dimerisation has been suggested as a novel drug target. Further, the ability of RT to dimerise is suggested to play a regulatory role in Gag-Pol processing and proteolytic generation of the mature R T heterodimer. Thus targeting R T dimerisation could potentially disturb both the early and late phases of HIV -1 replication, achieving dual modes of inhibition with a single compound. The present study validates this concept, and provides insight into the role of the RT domain in the late phase of HIV -1 replication. These observations were made upon examining the effect of mutating residues belonging to or associated with the highly conserved RT tryptophan repeat motif (TRM).The TRM is comprised of a cluster of six tryptophan residues at RT codons 398, 401, 402, 406 and410, and includes a tyrosine at codon 405. The motif is located in the connection subdomain, falling within secondary structural elements aL, f320 and the intervening loop linking these structures. The p66 aL-f320 loop protrudes into the pSI subunit, contributing to a major point of interaction at the RT heterodimer interface. Non-conservative mutation of the TRM residue W40I to alanine or leucine significantly diminishes RT subunit interaction, and accordingly RT activity. The dimerisation defect conferred by these mutations is predominantly mediated through the p66subunit. In the p66 subunit W40I does not directly contribute to the heterodimer interface. Rather, W401 is located at the C-terminal of aL where it is proposed to have an essential role in maintaining the position of the p66 aL-f320 loop, and hence the interactions contributed by aL-f320 loop residues to the heterodimer interface. In contrast, the conservative substitution, W401F, does not affect the ability of the RT subunits to dimerise, indicating the importance of an aromatic residue at this location.The role of the p66 aL-f320 loop in RT subunit interaction is supported by mutagenic analysis of other residues in this region. Non-conservative mutation of the TRM residue W4I4, which anchors the C-terminal of the loop in f320, and ofK331, which interacts with the p66 aL-f320 loop in the pSI subunit, also perturb RT subunit dimerisation. A second-site compensatory mutation, T4091,which partially suppresses the dimerisation defected conferred by the W401A mutation, is located within the aL-f320 loop.These data strongly support the proposal of an RT dimerisation defected mediated by the position of the aL-~20 loop at the heterodimer interface. It was proposed that mutation of these residues in HIV -1 would allow examination of the role of RT subunit interaction in HIV -1 replication in the absence of pleiotropic effects that have been described for other R T mutations.Expression of TRM mutants that abrogate R T dimerisation (W 401 AIL) resulted in HIV -1 with significant decreases in levels of virion R T. Variation in the p5I :p66 ratio in viral and producer cell lysates suggested that these mutations affected proteolytic generation of mature R T. These defects were RT specific with no accompanying decrease in virion Gag-Pol or IN. Virion particle production and Gag processing resembled that of wild-type HIV -1, indicating PR activation was not affected. A similar range of defects was apparent upon expression of the dimerisation defective K33IA mutation in HIV-l.In contrast expression of the W40IF mutation, which does not adversely affect RT subunit dimerisation, conferred no significant defects when expressed in HIV -1. Furthermore, generation of a replication competent virus by passage of the W 401 A HIV -1 mutant identified three second-site mutations, CI62Y, K366R and A534T. These mutations also restored RT dimerisation to the W40IA mutant in a recombinant protein binding assay. These observations strongly suggested that the defects observed upon expression of dimerisation defective mutations were representative of the role of R T dimerisation in HIV -1 replication.While the effect of the W 401 mutations in HIV -1 replication corresponded well with their role in RT heterodimerisation, examination of other TRM residues indicated an independent role in HIV-1replication. Expression of TRM mutants W398A and W 414A in HIV -1 resulted in reduced levels of virion Gag-Pol, RT and IN. These mutations were also found to change the Gag-Pol processing profile in a recombinant Gag-Pol expression system. The W401A second-site compensatory mutation identified in recombinant protein studies, T4091, also resulted in a similar profile when expressed in HIV -1 and recombinant Gag-Pol. Accordingly, this mutation did not act to suppress the defects conferred by W401A in HIV-1 replication. Interestingly, neither T409I nor W398Ainhibit RT subunit dimerisation or RT activity in recombinant RT. The contrasting effect of these mutations in recombinant RT compared to HIV-I demonstrates the dynamic nature of the RTdomain during maturation. This may be representative of a role for the TRM in regulation of GagPol cleavage events performed by the embedded PR either directly, or by interaction with regulatory host cell factors.These findings confirm that dimerisation of the HIV -1 RT domain has an important role in both the early and late phases of HIV -1 replication. Late phase defects were restricted to the proteolytic generation of mature RT, and no adverse effect on PR activation was observed. However this study identified the TRM as a key region in two independent stages of the late phase of HIV -1 replication,that being a defect in generation of a mature RT heterodimer upon disturbing RT dimerisation, and a dimerisation independent Gag-Pol processing defect. However, mutational analysis ofW414, and the combined defect of the W401A and T4091 mutations indicate that these defects can occur simultaneously. These data confirm the role of the TRM as a key region for RT interactions necessary for RT maturation and activity.


Viral Genome Replication

Viral Genome Replication

Author: Craig E. Cameron

Publisher: Springer Science & Business Media

Published: 2009-05-28

Total Pages: 636

ISBN-13: 038789456X

DOWNLOAD EBOOK

This book provides the first comprehensive review of viral genome replication strategies, emphasizing not only pathways and regulation but also the structure-function, mechanism, and inhibition of proteins and enzymes required for this process.


Human Immunodeficiency Virus Reverse Transcriptase

Human Immunodeficiency Virus Reverse Transcriptase

Author: Stuart LeGrice

Publisher: Springer Science & Business Media

Published: 2013-07-23

Total Pages: 358

ISBN-13: 1461472911

DOWNLOAD EBOOK

The Reverse Transcriptase (RT) of Human Immunodeficiency Virus Type 1 (HIV-1) arguably ranks amongst one of the most extensively studied retroviral enzymes. Heterologous expression and purification of HIV-1 RT in the early eighties, approval of the first nucleoside analogue RT inhibitor (NRTI) in 1987, discovery of resistance to RT inhibitors, approval of the first non-nucleoside analogue RT inhibitor (NNRTI) in 1996 and the various crystal structures of RT with and without bound substrate(s) and/or inhibitors represent only a few of the important milestones that describe the a bench-to-bedside success in the continuing effort to combat HIV-1 infection and its consequences. Nucleoside and nonnucleoside RT inhibitors remain important components in frequently used drug regimens to treat the infection. RT inhibitors also play important roles in recently validated strategies to prevent transmission of the virus. The relevance of HIV-1 RT as a drug target has simultaneously triggered interest in basic research studies aimed at providing a more detailed understanding of interactions between proteins, nucleic acids, and small molecule ligands in general terms. In light of the ever-growing knowledge on structure and function of HIV-1 RT, this enzyme serves as a valuable “model system” in efforts to develop novel experimental tools and to explain biochemical processes. This monograph is designed to provide an overview of important aspects in past and current HIV-1 RT research, with focus on mechanistic aspects and translation of knowledge into drug discovery and development. The first section includes chapters with emphasis placed on the coordination of the RT-associated DNA polymerase and ribonuclease H (RNase H) activities. The second covers mechanisms of action and future perspectives associated with NRTIs and NNRTIs, while the third section includes chapters focusing on novel strategies to target the RT enzyme. Chapters of the final part are intended to discuss mechanisms involved in HIV variability and the development of drug resistance. We hope that these contributions will stimulate interest, and encourage research aimed at the development of novel RT inhibitors. The lack of bona fide RNase H inhibitors with potent antiviral activity provides an example for challenges and opportunities in the field.


Viral Genes: Advances in Research and Application: 2011 Edition

Viral Genes: Advances in Research and Application: 2011 Edition

Author:

Publisher: ScholarlyEditions

Published: 2012-01-09

Total Pages: 40

ISBN-13: 1464949603

DOWNLOAD EBOOK

Viral Genes: Advances in Research and Application: 2011 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Viral Genes in a compact format. The editors have built Viral Genes: Advances in Research and Application: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Viral Genes in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Viral Genes: Advances in Research and Application: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.


Index Medicus

Index Medicus

Author:

Publisher:

Published: 2003

Total Pages: 1972

ISBN-13:

DOWNLOAD EBOOK

Vols. for 1963- include as pt. 2 of the Jan. issue: Medical subject headings.


Virus Diseases: New Insights for the Healthcare Professional: 2011 Edition

Virus Diseases: New Insights for the Healthcare Professional: 2011 Edition

Author:

Publisher: ScholarlyEditions

Published: 2012-01-09

Total Pages: 708

ISBN-13: 1464900116

DOWNLOAD EBOOK

Virus Diseases: New Insights for the Healthcare Professional: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Virus Diseases. The editors have built Virus Diseases: New Insights for the Healthcare Professional: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Virus Diseases in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Virus Diseases: New Insights for the Healthcare Professional: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.


Recoding: Expansion of Decoding Rules Enriches Gene Expression

Recoding: Expansion of Decoding Rules Enriches Gene Expression

Author: John F. Atkins

Publisher: Springer Science & Business Media

Published: 2010-03-10

Total Pages: 473

ISBN-13: 0387893822

DOWNLOAD EBOOK

The literature on recoding is scattered, so this superb book ?lls a need by prov- ing up-to-date, comprehensive, authoritative reviews of the many kinds of recoding phenomena. Between 1961 and 1966 my colleagues and I deciphered the genetic code in Escherichia coli and showed that the genetic code is the same in E. coli, Xenopus laevis, and guinea pig tissues. These results showed that the code has been c- served during evolution and strongly suggested that the code appeared very early during biological evolution, that all forms of life on earth descended from a c- mon ancestor, and thus that all forms of life on this planet are related to one another. The problem of biological time was solved by encoding information in DNA and retrieving the information for each new generation, for it is easier to make a new organism than it is to repair an aging, malfunctioning one. Subsequently, small modi?cations of the standard genetic code were found in certain organisms and in mitochondria. Mitochondrial DNA only encodes about 10–13 proteins, so some modi?cations of the genetic code are tolerated that pr- ably would be lethal if applied to the thousands of kinds of proteins encoded by genomic DNA.


Metals in Biological Systems

Metals in Biological Systems

Author: Maureen J. Kendrick

Publisher: Ellis Horwood

Published: 1992

Total Pages: 192

ISBN-13:

DOWNLOAD EBOOK

An examination of the ocurrence of 14 transitional and alkali metals in biological systems, including the structural and physical techniques used to detect and characterize these metal sites. There is also a section focusing on the interaction of inorganic drugs with biomolecules, such as DNA.


Flexible Viruses

Flexible Viruses

Author: Vladimir Uversky

Publisher: John Wiley & Sons

Published: 2012-02-07

Total Pages: 532

ISBN-13: 0470618310

DOWNLOAD EBOOK

This book provides up-to-date information on experimental and computational characterization of the structural and functional properties of viral proteins, which are widely involved in regulatory and signaling processes. With chapters by leading research groups, it features current information on the structural and functional roles of intrinsic disorders in viral proteomes. It systematically addresses the measles, HIV, influenza, potato virus, forest virus, bovine virus, hepatitis, and rotavirus as well as viral genomics. After analyzing the unique features of each class of viral proteins, future directions for research and disease management are presented.